Man Group
LHDX

Man Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Man Group’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,415
Closed -$44K – 2502
2022
Q1 		$44K Sell
12,415
-254
-2% -$1.25K ﹤0.01% 2126
2021
Q4 		$109K Buy
+12,669
New +$80.6K ﹤0.01% 1879

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
CWA
Choice Wealth Advisors Waterville, Maine $285M AUM 19.08% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Man Group's LHDX Position: Q2 2022 in Review

Man Group sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2022, closing a stake of 12,415 shares — an estimated $44K sold.

Man Group first reported a position in LHDX in Q4 2021 and held it in 2 quarters. The position peaked at $109K in Q4 2021. 38 funds tracked by Wall St. Rank hold LHDX as of Q2 2022.

  • Man Group reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Man Group sold 12,415 Lucira Health, Inc. Common Stock shares in Q2 2022, an estimated $44K.
  • Man Group first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Man Group's Lucira Health, Inc. Common Stock position peaked at $109K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.